Literature DB >> 34931221

Deviation from baseline mutation burden provides powerful and robust rare-variants association test for complex diseases.

Lin Jiang1,2,3,4, Hui Jiang1,3,4, Sheng Dai1,3,4, Ying Chen1,3,4, Youqiang Song5,6, Clara Sze-Man Tang7,8, Shirley Yin-Yu Pang9, Shu-Leong Ho9, Binbin Wang10, Maria-Mercedes Garcia-Barcelo7, Paul Kwong-Hang Tam7,8,11, Stacey S Cherny12, Mulin Jun Li13, Pak Chung Sham14,6,15, Miaoxin Li1,3,4,14,16.   

Abstract

Identifying rare variants that contribute to complex diseases is challenging because of the low statistical power in current tests comparing cases with controls. Here, we propose a novel and powerful rare variants association test based on the deviation of the observed mutation burden of a gene in cases from a baseline predicted by a weighted recursive truncated negative-binomial regression (RUNNER) on genomic features available from public data. Simulation studies show that RUNNER is substantially more powerful than state-of-the-art rare variant association tests and has reasonable type 1 error rates even for stratified populations or in small samples. Applied to real case-control data, RUNNER recapitulates known genes of Hirschsprung disease and Alzheimer's disease missed by current methods and detects promising new candidate genes for both disorders. In a case-only study, RUNNER successfully detected a known causal gene of amyotrophic lateral sclerosis. The present study provides a powerful and robust method to identify susceptibility genes with rare risk variants for complex diseases.
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Year:  2022        PMID: 34931221      PMCID: PMC8989543          DOI: 10.1093/nar/gkab1234

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  59 in total

Review 1.  Rho-linked genes and neurological disorders.

Authors:  Nael Nadif Kasri; Linda Van Aelst
Journal:  Pflugers Arch       Date:  2007-11-15       Impact factor: 3.657

Review 2.  Rare-variant association analysis: study designs and statistical tests.

Authors:  Seunggeung Lee; Gonçalo R Abecasis; Michael Boehnke; Xihong Lin
Journal:  Am J Hum Genet       Date:  2014-07-03       Impact factor: 11.025

3.  Searching for missing heritability: designing rare variant association studies.

Authors:  Or Zuk; Stephen F Schaffner; Kaitlin Samocha; Ron Do; Eliana Hechter; Sekar Kathiresan; Mark J Daly; Benjamin M Neale; Shamil R Sunyaev; Eric S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-17       Impact factor: 11.205

Review 4.  The developmental etiology and pathogenesis of Hirschsprung disease.

Authors:  Naomi E Butler Tjaden; Paul A Trainor
Journal:  Transl Res       Date:  2013-03-22       Impact factor: 7.012

Review 5.  Common and rare variants in multifactorial susceptibility to common diseases.

Authors:  Walter Bodmer; Carolina Bonilla
Journal:  Nat Genet       Date:  2008-06       Impact factor: 38.330

6.  Effect of population stratification analysis on false-positive rates for common and rare variants.

Authors:  Hua He; Xue Zhang; Lili Ding; Tesfaye M Baye; Brad G Kurowski; Lisa J Martin
Journal:  BMC Proc       Date:  2011-11-29

7.  Plasma Homocysteine and Serum Folate and Vitamin B12 Levels in Mild Cognitive Impairment and Alzheimer's Disease: A Case-Control Study.

Authors:  Fei Ma; Tianfeng Wu; Jiangang Zhao; Lu Ji; Aili Song; Meilin Zhang; Guowei Huang
Journal:  Nutrients       Date:  2017-07-08       Impact factor: 5.717

8.  ProxECAT: Proxy External Controls Association Test. A new case-control gene region association test using allele frequencies from public controls.

Authors:  Audrey E Hendricks; Stephen C Billups; Hamish N C Pike; I Sadaf Farooqi; Eleftheria Zeggini; Stephanie A Santorico; Inês Barroso; Josée Dupuis
Journal:  PLoS Genet       Date:  2018-10-16       Impact factor: 5.917

Review 9.  PCSK9 inhibitors: A new era of lipid lowering therapy.

Authors:  Rahul Chaudhary; Jalaj Garg; Neeraj Shah; Andrew Sumner
Journal:  World J Cardiol       Date:  2017-02-26

10.  The mutational constraint spectrum quantified from variation in 141,456 humans.

Authors:  Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 69.504

View more
  2 in total

Review 1.  Opportunities and challenges for the use of common controls in sequencing studies.

Authors:  Genevieve L Wojcik; Jessica Murphy; Jacob L Edelson; Christopher R Gignoux; Alexander G Ioannidis; Alisa Manning; Manuel A Rivas; Steven Buyske; Audrey E Hendricks
Journal:  Nat Rev Genet       Date:  2022-05-17       Impact factor: 59.581

2.  Investigating the biochemical effects of heat stress and sample quenching approach on the metabolic profiling of abalone (Haliotis iris).

Authors:  Thao V Nguyen; Andrea Alfaro; Emily Frost; Donglin Chen; David J Beale; Craig Mundy
Journal:  Metabolomics       Date:  2021-12-27       Impact factor: 4.290

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.